Zhejiang Shengda Bio-Pharm Co., Ltd. (SHA:603079)
China
· Delayed Price · Currency is CNY 17.92
-0.06 (-0.33%)
Mar 11, 2026, 2:14 PM CST
SHA:603079 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 549.24 | 315.62 | 323.72 | 320.72 | 514.75 | 461.31 | Upgrade
|
| Short-Term Investments | 21.55 | 30 | - | 10 | 20.07 | 110.11 | Upgrade
|
| Trading Asset Securities | 12.02 | 0.01 | 3.01 | - | 0.01 | - | Upgrade
|
| Cash & Short-Term Investments | 582.81 | 345.63 | 326.74 | 330.72 | 534.83 | 571.42 | Upgrade
|
| Cash Growth | 137.13% | 5.78% | -1.20% | -38.16% | -6.40% | 40.20% | Upgrade
|
| Accounts Receivable | 155.97 | 141.24 | 119.26 | 135.9 | 133.38 | 115.02 | Upgrade
|
| Other Receivables | 0.36 | 0.55 | 0.6 | 0.85 | 0.17 | 0.4 | Upgrade
|
| Receivables | 156.33 | 141.79 | 119.86 | 136.75 | 133.55 | 115.42 | Upgrade
|
| Inventory | 194.89 | 197.54 | 228.48 | 292.06 | 222.09 | 167.94 | Upgrade
|
| Other Current Assets | 26.67 | 23.81 | 20.07 | 20.83 | 28.35 | 26.36 | Upgrade
|
| Total Current Assets | 960.69 | 708.77 | 695.15 | 780.36 | 918.81 | 881.15 | Upgrade
|
| Property, Plant & Equipment | 886.37 | 769.47 | 674.77 | 561.81 | 579.96 | 576.02 | Upgrade
|
| Long-Term Investments | 10.7 | 21.01 | 60.7 | 60.7 | 20.74 | 10.7 | Upgrade
|
| Goodwill | 10.91 | 10.91 | 10.91 | 10.91 | 10.91 | 10.91 | Upgrade
|
| Other Intangible Assets | 224.83 | 225.58 | 231.82 | 218.2 | 156.09 | 165.59 | Upgrade
|
| Long-Term Deferred Tax Assets | 0.23 | 0.06 | 0.89 | 5.36 | 3.38 | 2.89 | Upgrade
|
| Long-Term Deferred Charges | 3.1 | 6.16 | 8.67 | 4.23 | 6.87 | 11.18 | Upgrade
|
| Other Long-Term Assets | 49.44 | 43.35 | 36.28 | 13.64 | 68.06 | 42.44 | Upgrade
|
| Total Assets | 2,146 | 1,785 | 1,719 | 1,655 | 1,765 | 1,701 | Upgrade
|
| Accounts Payable | 172.09 | 155.44 | 129.61 | 164 | 151.33 | 106.78 | Upgrade
|
| Accrued Expenses | 19.78 | 38.31 | 33.84 | 37.57 | 36.03 | 36.14 | Upgrade
|
| Short-Term Debt | - | 30.82 | 94.75 | 41.76 | 167.39 | 121.23 | Upgrade
|
| Current Portion of Long-Term Debt | 0.48 | 0.11 | 0.14 | - | - | - | Upgrade
|
| Current Portion of Leases | - | 0.8 | 0.3 | 0.59 | 0.59 | - | Upgrade
|
| Current Income Taxes Payable | 18.41 | 3.38 | 2.98 | 5.04 | 3.21 | 20.02 | Upgrade
|
| Current Unearned Revenue | 5.54 | 3.8 | 2.92 | 8.7 | 6.54 | 4.04 | Upgrade
|
| Other Current Liabilities | 1.79 | 18.71 | 30.9 | 37.81 | 47.4 | 70.56 | Upgrade
|
| Total Current Liabilities | 218.09 | 251.38 | 295.45 | 295.46 | 412.5 | 358.76 | Upgrade
|
| Long-Term Debt | 305.5 | 231 | 144 | - | - | - | Upgrade
|
| Long-Term Leases | - | 0.49 | - | 0.3 | 0.87 | - | Upgrade
|
| Long-Term Unearned Revenue | 7.04 | 6.65 | 5.46 | 7.58 | 6.95 | 4.69 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 3.42 | 3.71 | 4.28 | 8.43 | 7.53 | 6.44 | Upgrade
|
| Other Long-Term Liabilities | 8.1 | 8.1 | - | - | - | 5.92 | Upgrade
|
| Total Liabilities | 542.15 | 501.34 | 449.2 | 311.78 | 427.84 | 375.8 | Upgrade
|
| Common Stock | 189.03 | 171.19 | 171.19 | 171.19 | 171.19 | 171.19 | Upgrade
|
| Additional Paid-In Capital | 912.78 | 669.19 | 669.19 | 669.19 | 669.19 | 669.19 | Upgrade
|
| Retained Earnings | 495.87 | 442.53 | 423.26 | 487.6 | 480.09 | 464.25 | Upgrade
|
| Treasury Stock | -22.08 | -22.08 | -8.97 | - | - | - | Upgrade
|
| Total Common Equity | 1,576 | 1,261 | 1,255 | 1,328 | 1,320 | 1,305 | Upgrade
|
| Minority Interest | 28.53 | 23.14 | 15.31 | 15.45 | 16.49 | 20.43 | Upgrade
|
| Shareholders' Equity | 1,604 | 1,284 | 1,270 | 1,343 | 1,337 | 1,325 | Upgrade
|
| Total Liabilities & Equity | 2,146 | 1,785 | 1,719 | 1,655 | 1,765 | 1,701 | Upgrade
|
| Total Debt | 305.98 | 263.23 | 239.2 | 42.65 | 168.85 | 121.23 | Upgrade
|
| Net Cash (Debt) | 276.83 | 82.4 | 87.54 | 288.07 | 365.98 | 450.19 | Upgrade
|
| Net Cash Growth | 6892.99% | -5.86% | -69.61% | -21.29% | -18.70% | 777.43% | Upgrade
|
| Net Cash Per Share | 1.53 | 0.48 | 0.52 | 1.65 | 2.13 | 2.67 | Upgrade
|
| Filing Date Shares Outstanding | 187.16 | 169.32 | 169.32 | 171.19 | 171.19 | 171.19 | Upgrade
|
| Total Common Shares Outstanding | 187.16 | 169.32 | 170.46 | 171.19 | 171.19 | 171.19 | Upgrade
|
| Working Capital | 742.6 | 457.38 | 399.69 | 484.9 | 506.32 | 522.39 | Upgrade
|
| Book Value Per Share | 8.42 | 7.45 | 7.36 | 7.76 | 7.71 | 7.62 | Upgrade
|
| Tangible Book Value | 1,340 | 1,024 | 1,012 | 1,099 | 1,153 | 1,128 | Upgrade
|
| Tangible Book Value Per Share | 7.16 | 6.05 | 5.94 | 6.42 | 6.74 | 6.59 | Upgrade
|
| Buildings | - | 290.21 | 279.73 | 274.11 | 272.42 | 271.23 | Upgrade
|
| Machinery | - | 589.14 | 528.41 | 515.04 | 479.2 | 449.64 | Upgrade
|
| Construction In Progress | - | 335.96 | 247.32 | 93.33 | 88.76 | 61.42 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.